Health-Related Quality of Life With Pembrolizumab vs Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181
J. Clin. Oncol 2021 Nov 03;[EPub Ahead of Print], A Adenis, AS Kulkarni, GC Girotto, C de la Fouchardiere, H Senellart, HWM van Laarhoven, W Mansoor, R Al-Rajabi, J Norquist, M Amonkar, S Suryawanshi, P Bhagia, JP MetgesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.